Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts WALKER LANE PROVIDES UPDATE ON LATE FILING OF FINANCIAL STATEMENTS February 13, 2026 RUA GOLD Announces Uplisting to Toronto Stock Exchange February 13, 2026 Copper Quest Announces Securities for Debt Settlement February 13, 2026